DIABETIC PATIENTS' COMPLIANCE WITH TREATMENT DURING COVID-19 PANDEMIC PERIOD/COVID-19 PANDEMI DONEMINDE DIYABET HASTASININ TEDAVIYE UYUM DURUMUNUN DEGERLENDIRILMESI
Objective: Diabetes mellitus is a chronic, complex disease with many components that must be managed. Treatment success depends on excellent treatment compliance. In this study, we aimed to evaluate the treatment adherence of diabetic patients during the COVID-19 (Coronavirus Disease) pandemic and t...
Gespeichert in:
| Veröffentlicht in: | İstanbul Tıp Fakültesi dergisi = Journal of the Istanbul Faculty of Medicine 2022-12, Vol.85 (4), p.485 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 4 |
| container_start_page | 485 |
| container_title | İstanbul Tıp Fakültesi dergisi = Journal of the Istanbul Faculty of Medicine |
| container_volume | 85 |
| creator | Basmakci, Ayse Kutlu, Orkide Kalyon, Semih Sertdemir, Tulay Adas, Mine |
| description | Objective: Diabetes mellitus is a chronic, complex disease with many components that must be managed. Treatment success depends on excellent treatment compliance. In this study, we aimed to evaluate the treatment adherence of diabetic patients during the COVID-19 (Coronavirus Disease) pandemic and the factors affecting this condition. Material and Methods: The study was carried out on 474 diabetic patients with a questionnaire consisting of questions based on The Medication Compliance Questionnaire (MCQ) and the World Health Organization (WHO) 2003 compliance guideline. Results: The rate of non-compliance with the treatment based on the MCQ scale was 82.3%. Non-compliance with treatment was significantly associated with oral antidiabetic (OAD) drug use, smoking status, glycosylated hemoglobin (HbA1c) |
| doi_str_mv | 10.26650/IUITFD.1050290 |
| format | Article |
| fullrecord | <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A731237660</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A731237660</galeid><sourcerecordid>A731237660</sourcerecordid><originalsourceid>FETCH-LOGICAL-g670-5df383080a6c3f9296d5a71a4a3cd40ce78bcb4d5f5291f619781e37f952c38a3</originalsourceid><addsrcrecordid>eNptjT9PwzAQxTOARFU6s1piYEqx49hJRhO77UmJUyVOUafKdZIqqH8kwkfig5IKBoTQDe907_3eed4DwfOAc4afoQazkHOCGQ4SfONNCMXM5yGld95sGN4wxgEjhOFw4n1KEC_KQIrWwoDSpnpCaZGvMxA6VegVzAqZUgmTjx6SdQl6OQY2IH2SjIyWKr_CqoRCPv81kCz0KOOOJGyvj9BKVEZUoEEjo6TYwFahelvn1-46r3WtkVRLVWZKSyghy1UF995tZ49DO_vRqWcWyqQrPyuWkIrMP_AI-6zpaExxjC13tEuChDfMRsSGlromxK6N4r3bhw3rWJCQjpMkiklLoy5hgaOxpVPv8bv2YI_trj93l49360794HYioiSgEed4TM3_SY3TtKfeXc5t14_3X8AX8Ldt4w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>DIABETIC PATIENTS' COMPLIANCE WITH TREATMENT DURING COVID-19 PANDEMIC PERIOD/COVID-19 PANDEMI DONEMINDE DIYABET HASTASININ TEDAVIYE UYUM DURUMUNUN DEGERLENDIRILMESI</title><source>DOAJ Directory of Open Access Journals</source><source>Alma/SFX Local Collection</source><creator>Basmakci, Ayse ; Kutlu, Orkide ; Kalyon, Semih ; Sertdemir, Tulay ; Adas, Mine</creator><creatorcontrib>Basmakci, Ayse ; Kutlu, Orkide ; Kalyon, Semih ; Sertdemir, Tulay ; Adas, Mine</creatorcontrib><description>Objective: Diabetes mellitus is a chronic, complex disease with many components that must be managed. Treatment success depends on excellent treatment compliance. In this study, we aimed to evaluate the treatment adherence of diabetic patients during the COVID-19 (Coronavirus Disease) pandemic and the factors affecting this condition. Material and Methods: The study was carried out on 474 diabetic patients with a questionnaire consisting of questions based on The Medication Compliance Questionnaire (MCQ) and the World Health Organization (WHO) 2003 compliance guideline. Results: The rate of non-compliance with the treatment based on the MCQ scale was 82.3%. Non-compliance with treatment was significantly associated with oral antidiabetic (OAD) drug use, smoking status, glycosylated hemoglobin (HbA1c) <7%, and patient comments of "I don't have regular doctor follow-up," "I can't communicate well with my doctor," "My blood glucose is not at the target value," and "My medications are not comfortable enough for use"(p=0.011; 0.010; 0.014; 0.011; 0.002; 0.019; 0.001). Patients under insulin treatment or with an HbA1c value of [greater than or equal to]7% were found to be more compliant with the treatment. Conclusion: Unlike the classical results, the incompatibility of diabetic patients with HbA1c <7% and under OADs with the treatment was emphasized. Patients using insulin and with advanced duration of diabetes were more compliant with the treatment in the stressful period of the COVID-19 pandemic. Lack of follow-up by the doctor and low patient effort to communicate with the doctor have been decisive factors in the non-compliance. Keywords: Diabetes mellitus, compliance, HbA1c, oral antiglycemic agent Amac: Diyabet, yonetimi cok bilesenli olan kronik, kompleks bir hastaliktir. Tedavi basarisi ancak iyi bir tedavi uyumuyla saglanabilmektedir. Bu calismada, diyabet hastalarinin COVID-19 (Koronavirus hastaligi) pandemisi doneminde tedaviye uyum durumu ve bu durumu etkileyen faktorlerin degerlendirilmesi amaclandi. Gerec ve Yontem: Calisma, The Medication Compliance Questionnaire (MCQ) ve Dunya Saglik Orgutu (DSO) uyum klavuzu 2003'e gore belirlenmis sorularindan olusan bir anket ile 474 diyabetik hasta ile gerceklestirilmistir. Bulgular: MCQ olcegine gore tedaviye uyumsuzluk orani %82,3 idi. Tedaviye uyumsuzluk, oral antidiyabetik (OAD) ilac kullanimi, sigara icme durumu, glukolize hemoglobinin (HbA1c) <%7 olmasi ve hasta yorum sorularindan; "duzenli doktor takibim yok","doktorumla iyi iletisim kuramiyorum", "sekerim belirlenen hedef degerde degil","ilaclarim kullanim yonunden yeterince konforlu degil" ifadeleriyle iliskili bulunmustur (p=0,011; 0,010; 0,014; 0,011; 0,002; 0,019; 0,000). Insulin kullanan, HbA1c degeri [greater than or equal to]%7 olan hastalar ise tedaviye daha uyumlu olarak tespit edilmistir. Sonuc: Bu calismada klasik sonuclardan farkli olarak HbA1c <%7 ve OAD kullanmakta olan diyabetik hastalarin uyumsuzlugu gundeme getirilmistir. COVID-19 pandemisi doneminde insulin kullanan ve hastalik suresi uzun olan hastalar tedaviye daha bagli kalmislardir. Doktor takibinin olmamasi ve doktorla iyi iletisim kuramama uyumsuzluk acisindan belirleyici olmustur. Anahtar Kelimeler: Diyabetes mellitus, tedavi uyumu, HbA1c, oral antidiyabetik ilac</description><identifier>ISSN: 1305-6433</identifier><identifier>DOI: 10.26650/IUITFD.1050290</identifier><language>eng</language><publisher>Istanbul University Press</publisher><subject>Behavior ; Diabetics ; Drug therapy ; Epidemics ; Patient compliance ; Surveys ; Turkey</subject><ispartof>İstanbul Tıp Fakültesi dergisi = Journal of the Istanbul Faculty of Medicine, 2022-12, Vol.85 (4), p.485</ispartof><rights>COPYRIGHT 2022 Istanbul University Press</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids></links><search><creatorcontrib>Basmakci, Ayse</creatorcontrib><creatorcontrib>Kutlu, Orkide</creatorcontrib><creatorcontrib>Kalyon, Semih</creatorcontrib><creatorcontrib>Sertdemir, Tulay</creatorcontrib><creatorcontrib>Adas, Mine</creatorcontrib><title>DIABETIC PATIENTS' COMPLIANCE WITH TREATMENT DURING COVID-19 PANDEMIC PERIOD/COVID-19 PANDEMI DONEMINDE DIYABET HASTASININ TEDAVIYE UYUM DURUMUNUN DEGERLENDIRILMESI</title><title>İstanbul Tıp Fakültesi dergisi = Journal of the Istanbul Faculty of Medicine</title><description>Objective: Diabetes mellitus is a chronic, complex disease with many components that must be managed. Treatment success depends on excellent treatment compliance. In this study, we aimed to evaluate the treatment adherence of diabetic patients during the COVID-19 (Coronavirus Disease) pandemic and the factors affecting this condition. Material and Methods: The study was carried out on 474 diabetic patients with a questionnaire consisting of questions based on The Medication Compliance Questionnaire (MCQ) and the World Health Organization (WHO) 2003 compliance guideline. Results: The rate of non-compliance with the treatment based on the MCQ scale was 82.3%. Non-compliance with treatment was significantly associated with oral antidiabetic (OAD) drug use, smoking status, glycosylated hemoglobin (HbA1c) <7%, and patient comments of "I don't have regular doctor follow-up," "I can't communicate well with my doctor," "My blood glucose is not at the target value," and "My medications are not comfortable enough for use"(p=0.011; 0.010; 0.014; 0.011; 0.002; 0.019; 0.001). Patients under insulin treatment or with an HbA1c value of [greater than or equal to]7% were found to be more compliant with the treatment. Conclusion: Unlike the classical results, the incompatibility of diabetic patients with HbA1c <7% and under OADs with the treatment was emphasized. Patients using insulin and with advanced duration of diabetes were more compliant with the treatment in the stressful period of the COVID-19 pandemic. Lack of follow-up by the doctor and low patient effort to communicate with the doctor have been decisive factors in the non-compliance. Keywords: Diabetes mellitus, compliance, HbA1c, oral antiglycemic agent Amac: Diyabet, yonetimi cok bilesenli olan kronik, kompleks bir hastaliktir. Tedavi basarisi ancak iyi bir tedavi uyumuyla saglanabilmektedir. Bu calismada, diyabet hastalarinin COVID-19 (Koronavirus hastaligi) pandemisi doneminde tedaviye uyum durumu ve bu durumu etkileyen faktorlerin degerlendirilmesi amaclandi. Gerec ve Yontem: Calisma, The Medication Compliance Questionnaire (MCQ) ve Dunya Saglik Orgutu (DSO) uyum klavuzu 2003'e gore belirlenmis sorularindan olusan bir anket ile 474 diyabetik hasta ile gerceklestirilmistir. Bulgular: MCQ olcegine gore tedaviye uyumsuzluk orani %82,3 idi. Tedaviye uyumsuzluk, oral antidiyabetik (OAD) ilac kullanimi, sigara icme durumu, glukolize hemoglobinin (HbA1c) <%7 olmasi ve hasta yorum sorularindan; "duzenli doktor takibim yok","doktorumla iyi iletisim kuramiyorum", "sekerim belirlenen hedef degerde degil","ilaclarim kullanim yonunden yeterince konforlu degil" ifadeleriyle iliskili bulunmustur (p=0,011; 0,010; 0,014; 0,011; 0,002; 0,019; 0,000). Insulin kullanan, HbA1c degeri [greater than or equal to]%7 olan hastalar ise tedaviye daha uyumlu olarak tespit edilmistir. Sonuc: Bu calismada klasik sonuclardan farkli olarak HbA1c <%7 ve OAD kullanmakta olan diyabetik hastalarin uyumsuzlugu gundeme getirilmistir. COVID-19 pandemisi doneminde insulin kullanan ve hastalik suresi uzun olan hastalar tedaviye daha bagli kalmislardir. Doktor takibinin olmamasi ve doktorla iyi iletisim kuramama uyumsuzluk acisindan belirleyici olmustur. Anahtar Kelimeler: Diyabetes mellitus, tedavi uyumu, HbA1c, oral antidiyabetik ilac</description><subject>Behavior</subject><subject>Diabetics</subject><subject>Drug therapy</subject><subject>Epidemics</subject><subject>Patient compliance</subject><subject>Surveys</subject><subject>Turkey</subject><issn>1305-6433</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptjT9PwzAQxTOARFU6s1piYEqx49hJRhO77UmJUyVOUafKdZIqqH8kwkfig5IKBoTQDe907_3eed4DwfOAc4afoQazkHOCGQ4SfONNCMXM5yGld95sGN4wxgEjhOFw4n1KEC_KQIrWwoDSpnpCaZGvMxA6VegVzAqZUgmTjx6SdQl6OQY2IH2SjIyWKr_CqoRCPv81kCz0KOOOJGyvj9BKVEZUoEEjo6TYwFahelvn1-46r3WtkVRLVWZKSyghy1UF995tZ49DO_vRqWcWyqQrPyuWkIrMP_AI-6zpaExxjC13tEuChDfMRsSGlromxK6N4r3bhw3rWJCQjpMkiklLoy5hgaOxpVPv8bv2YI_trj93l49360794HYioiSgEed4TM3_SY3TtKfeXc5t14_3X8AX8Ldt4w</recordid><startdate>20221201</startdate><enddate>20221201</enddate><creator>Basmakci, Ayse</creator><creator>Kutlu, Orkide</creator><creator>Kalyon, Semih</creator><creator>Sertdemir, Tulay</creator><creator>Adas, Mine</creator><general>Istanbul University Press</general><scope/></search><sort><creationdate>20221201</creationdate><title>DIABETIC PATIENTS' COMPLIANCE WITH TREATMENT DURING COVID-19 PANDEMIC PERIOD/COVID-19 PANDEMI DONEMINDE DIYABET HASTASININ TEDAVIYE UYUM DURUMUNUN DEGERLENDIRILMESI</title><author>Basmakci, Ayse ; Kutlu, Orkide ; Kalyon, Semih ; Sertdemir, Tulay ; Adas, Mine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g670-5df383080a6c3f9296d5a71a4a3cd40ce78bcb4d5f5291f619781e37f952c38a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Behavior</topic><topic>Diabetics</topic><topic>Drug therapy</topic><topic>Epidemics</topic><topic>Patient compliance</topic><topic>Surveys</topic><topic>Turkey</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Basmakci, Ayse</creatorcontrib><creatorcontrib>Kutlu, Orkide</creatorcontrib><creatorcontrib>Kalyon, Semih</creatorcontrib><creatorcontrib>Sertdemir, Tulay</creatorcontrib><creatorcontrib>Adas, Mine</creatorcontrib><jtitle>İstanbul Tıp Fakültesi dergisi = Journal of the Istanbul Faculty of Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Basmakci, Ayse</au><au>Kutlu, Orkide</au><au>Kalyon, Semih</au><au>Sertdemir, Tulay</au><au>Adas, Mine</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>DIABETIC PATIENTS' COMPLIANCE WITH TREATMENT DURING COVID-19 PANDEMIC PERIOD/COVID-19 PANDEMI DONEMINDE DIYABET HASTASININ TEDAVIYE UYUM DURUMUNUN DEGERLENDIRILMESI</atitle><jtitle>İstanbul Tıp Fakültesi dergisi = Journal of the Istanbul Faculty of Medicine</jtitle><date>2022-12-01</date><risdate>2022</risdate><volume>85</volume><issue>4</issue><spage>485</spage><pages>485-</pages><issn>1305-6433</issn><abstract>Objective: Diabetes mellitus is a chronic, complex disease with many components that must be managed. Treatment success depends on excellent treatment compliance. In this study, we aimed to evaluate the treatment adherence of diabetic patients during the COVID-19 (Coronavirus Disease) pandemic and the factors affecting this condition. Material and Methods: The study was carried out on 474 diabetic patients with a questionnaire consisting of questions based on The Medication Compliance Questionnaire (MCQ) and the World Health Organization (WHO) 2003 compliance guideline. Results: The rate of non-compliance with the treatment based on the MCQ scale was 82.3%. Non-compliance with treatment was significantly associated with oral antidiabetic (OAD) drug use, smoking status, glycosylated hemoglobin (HbA1c) <7%, and patient comments of "I don't have regular doctor follow-up," "I can't communicate well with my doctor," "My blood glucose is not at the target value," and "My medications are not comfortable enough for use"(p=0.011; 0.010; 0.014; 0.011; 0.002; 0.019; 0.001). Patients under insulin treatment or with an HbA1c value of [greater than or equal to]7% were found to be more compliant with the treatment. Conclusion: Unlike the classical results, the incompatibility of diabetic patients with HbA1c <7% and under OADs with the treatment was emphasized. Patients using insulin and with advanced duration of diabetes were more compliant with the treatment in the stressful period of the COVID-19 pandemic. Lack of follow-up by the doctor and low patient effort to communicate with the doctor have been decisive factors in the non-compliance. Keywords: Diabetes mellitus, compliance, HbA1c, oral antiglycemic agent Amac: Diyabet, yonetimi cok bilesenli olan kronik, kompleks bir hastaliktir. Tedavi basarisi ancak iyi bir tedavi uyumuyla saglanabilmektedir. Bu calismada, diyabet hastalarinin COVID-19 (Koronavirus hastaligi) pandemisi doneminde tedaviye uyum durumu ve bu durumu etkileyen faktorlerin degerlendirilmesi amaclandi. Gerec ve Yontem: Calisma, The Medication Compliance Questionnaire (MCQ) ve Dunya Saglik Orgutu (DSO) uyum klavuzu 2003'e gore belirlenmis sorularindan olusan bir anket ile 474 diyabetik hasta ile gerceklestirilmistir. Bulgular: MCQ olcegine gore tedaviye uyumsuzluk orani %82,3 idi. Tedaviye uyumsuzluk, oral antidiyabetik (OAD) ilac kullanimi, sigara icme durumu, glukolize hemoglobinin (HbA1c) <%7 olmasi ve hasta yorum sorularindan; "duzenli doktor takibim yok","doktorumla iyi iletisim kuramiyorum", "sekerim belirlenen hedef degerde degil","ilaclarim kullanim yonunden yeterince konforlu degil" ifadeleriyle iliskili bulunmustur (p=0,011; 0,010; 0,014; 0,011; 0,002; 0,019; 0,000). Insulin kullanan, HbA1c degeri [greater than or equal to]%7 olan hastalar ise tedaviye daha uyumlu olarak tespit edilmistir. Sonuc: Bu calismada klasik sonuclardan farkli olarak HbA1c <%7 ve OAD kullanmakta olan diyabetik hastalarin uyumsuzlugu gundeme getirilmistir. COVID-19 pandemisi doneminde insulin kullanan ve hastalik suresi uzun olan hastalar tedaviye daha bagli kalmislardir. Doktor takibinin olmamasi ve doktorla iyi iletisim kuramama uyumsuzluk acisindan belirleyici olmustur. Anahtar Kelimeler: Diyabetes mellitus, tedavi uyumu, HbA1c, oral antidiyabetik ilac</abstract><pub>Istanbul University Press</pub><doi>10.26650/IUITFD.1050290</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1305-6433 |
| ispartof | İstanbul Tıp Fakültesi dergisi = Journal of the Istanbul Faculty of Medicine, 2022-12, Vol.85 (4), p.485 |
| issn | 1305-6433 |
| language | eng |
| recordid | cdi_gale_infotracmisc_A731237660 |
| source | DOAJ Directory of Open Access Journals; Alma/SFX Local Collection |
| subjects | Behavior Diabetics Drug therapy Epidemics Patient compliance Surveys Turkey |
| title | DIABETIC PATIENTS' COMPLIANCE WITH TREATMENT DURING COVID-19 PANDEMIC PERIOD/COVID-19 PANDEMI DONEMINDE DIYABET HASTASININ TEDAVIYE UYUM DURUMUNUN DEGERLENDIRILMESI |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T08%3A58%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=DIABETIC%20PATIENTS'%20COMPLIANCE%20WITH%20TREATMENT%20DURING%20COVID-19%20PANDEMIC%20PERIOD/COVID-19%20PANDEMI%20DONEMINDE%20DIYABET%20HASTASININ%20TEDAVIYE%20UYUM%20DURUMUNUN%20DEGERLENDIRILMESI&rft.jtitle=%C4%B0stanbul%20T%C4%B1p%20Fak%C3%BCltesi%20dergisi%20=%20Journal%20of%20the%20Istanbul%20Faculty%20of%20Medicine&rft.au=Basmakci,%20Ayse&rft.date=2022-12-01&rft.volume=85&rft.issue=4&rft.spage=485&rft.pages=485-&rft.issn=1305-6433&rft_id=info:doi/10.26650/IUITFD.1050290&rft_dat=%3Cgale%3EA731237660%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A731237660&rfr_iscdi=true |